Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 10Colorectal Neoplasms 5Ovarian Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Prostatic Neoplasms 3Rectal Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Hepatic Veno-Occlusive Disease 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Tamoxifen 1Megestrol Acetate 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Endometrial Hyperplasia × Genetic Testing × Clear all
NCT03338985 2018-01-05

Role of Senescence in the Development of Endometrial Cancer

CHU de Reims

Phase NA Unknown
140 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡